Page last updated: 2024-11-04

rolipram and Skin Neoplasms

rolipram has been researched along with Skin Neoplasms in 2 studies

Skin Neoplasms: Tumors or cancer of the SKIN.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kowalczyk, P1
Kinjo, T1
Kowalczyk, M1
Walaszek, Z1
Hanausek, M1
Slaga, TJ1
Marko, D1
Romanakis, K1
Zankl, H1
Fürstenberger, G1
Steinbauer, B1
Eisenbrand, G1

Other Studies

2 other studies available for rolipram and Skin Neoplasms

ArticleYear
Effect of phosphodiesterase antagonists on glucocorticoid mediated growth inhibition in murine skin cell lines.
    European journal of pharmacology, 2009, May-21, Volume: 610, Issue:1-3

    Topics: Animals; Carcinoma, Squamous Cell; Cell Line; Cell Line, Tumor; Cell Transformation, Neoplastic; Dos

2009
Induction of apoptosis by an inhibitor of cAMP-specific PDE in malignant murine carcinoma cells overexpressing PDE activity in comparison to their nonmalignant counterparts.
    Cell biochemistry and biophysics, 1998, Volume: 28, Issue:2-3

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenine; Animals; Carcinoma; Cell Cycle; Cell Division; Cell Si

1998